aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Kezar Life Sciences, founded with a mission to revolutionize the treatment of chronic diseases, focuses on developing molecular therapeutics targeting protein homeostasis for autoimmune disorders. Based in California, the company leverages its scientific expertise to create novel pathways that address the limitations of current treatments, aiming to improve patient outcomes in the healthcare sector.
Notable figures associated with Kezar Life Sciences include experienced scientists and industry experts who drive its innovative research. The company has garnered attention from key investors in the biotech field, contributing to its growth and development. Kezar's pioneering approaches have positioned it as a significant player in the biotechnology industry, making impactful strides in the treatment of autoimmune diseases.
Operating Status
Active
Ownership Type(s)
Public
Main Product(s)
Therapeutics, Medicines
Technology
Biotech
Tags
Biotech, Healthtech
Model Types
Biotech
Revenue Type(s)
Recurring
Customer Type(s)
Enterprise
Geographic Exposure
United States
When was Kezar Life Sciences founded?
Kezar Life Sciences was founded in 2015.
Where is Kezar Life Sciences's headquarters located?
Kezar Life Sciences's headquarters is located in South San Francisco, CA, US.
When was Kezar Life Sciences's last funding round?
Kezar Life Sciences's most recent funding round was for $50M (USD) in November 2021.
How many employees does Kezar Life Sciences have?
Kezar Life Sciences has 84 employees as of Feb 6, 2024.
How much has Kezar Life Sciences raised to-date?
As of July 05, 2023, Kezar Life Sciences has raised a total of $123M (USD) since Nov 10, 2021.
Add Comparison
Total Raised to Date
$123M
USD
Last Update Nov 10, 2021
Last Deal Details
$50M
USD
Nov 10, 2021
Post Ipo Debt
Total Employees Over Time
84
As of Feb 2024
Kezar Life Sciences Address
4000 Shoreline Ct
suite 300
South San Francisco,
California
94080-2005
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts